PIN16 COST-EFFECTIVENESS ANALYSIS OF FUZEON ADDED TO OPTIMAL STANDARD THERAPY VS. OPTIMIZED BACKGROUND REGIMEN ALONE IN PATIENTS WITH HIV/AIDS
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61913-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)61913-4/fulltext
Section Title :
Section Order :
359
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61913-4&doi=10.1016/S1098-3015(10)61913-4